Results 131 to 140 of about 277,312 (326)
Over the counter ophthalmic drug misuse, are we aware? [PDF]
, 2010 Aim: To investigate the misuse of ‘over the counter’ ophthalmic medications in our city. Method: Responses of a structured questionnaire covering various aspects of over the counter drug use was obtained from pharmacy workers in and around our city ...
Achar, A, Hegde, S, Kadri, R, Kudva, AA
core +1 more source
Assessing the painful, uninflamed eye in primary care [PDF]
, 2015 We acknowledge the important contributions of Professor Amada J Lee, University of Aberdeen, Division of Statistics, for assistance with analysing the data from the patient survey.
Dick, Andrew +2 more
core +1 more source
International Journal of Dermatology, EarlyView.ABSTRACT Background Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.
Yan Zhao +26 more
wiley +1 more source
Rhinitis in general practice [PDF]
, 2007 A 3 year old boy presented with a 3 week history of nasal obstruction, clear rhinorrhea, difficulty with feeding and a productive cough. Child was afebrile, had occasional watery itchy eyes and mother claimed that at night he tended to wake up a couple ...
drkvassallo@yahoo.co.uk +1 more
core
Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies : a retrospective observational study [PDF]
, 2017 Acknowledgments The abstract of this paper was presented at the Respiratory Effectiveness Group 2016 Annual Summit as a poster presentation with interim findings.
Bosnic-Anticevich, Sinthia Z +9 more
core +3 more sources
International Journal of Dermatology, EarlyView.ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo +11 more
wiley +1 more source
Conjunctivitis: Types, Clinical Manifestation and Management
JLUMHSThis narrative review analyses the different types, clinical manifestations, and management strategies for conjunctivitis to facilitate accurate diagnosis and treatment planning.
Mehwish Rubab, Sana Zahoor, Saba Ashraf
doaj +1 more source
A survey on features of allergic rhinitis in children [PDF]
, 2013 Objective: A number of epidemiologic studies evaluated the prevalence of allergic rhinitis (AR), but few data are available on its different clinical presentations.
), +11 more
core +1 more source
Prevalence of allergic conjunctivitis: a missed opportunity? [PDF]
, 2009 Carlos Antônio Riedi +1 more
openalex +1 more source
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
Journal of the European Academy of Dermatology and Venereology, EarlyView.This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source